Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategiesAbdallah Abou Zahr, John Mascarenhas, Mohamed E. Salama et al.|Haematologica|2016Cited by 194
Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosisJohn Mascarenhas, Ronald Hoffman, Lonette Sandy et al.|Leukemia & lymphoma/Leukemia and lymphoma|2019Cited by 19
Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow TransplantationRachel Phelan, Sarah C. Vij, Annie Im et al.|Transplantation and Cellular Therapy|2021Cited by 16